Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2007 2
2008 1
2013 1
2014 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Transportation to primary percutaneous coronary intervention, compared with on-site fibrinolysis, is a strong independent predictor of functional status after myocardial infarction: 5-year follow-up of the PRAGUE-2 trial.
Mocova Bilkova D, Motovska Z, Prochazka B, Groch L, Zelizko M, Aschermann M, Widimsky P; PRAGUE Study Group Investigators. Mocova Bilkova D, et al. Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):105-9. doi: 10.1177/2048872613516016. Epub 2013 Dec 4. Eur Heart J Acute Cardiovasc Care. 2014. PMID: 24337919 Clinical Trial.
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.
Widimský P, Budesínský T, Vorác D, Groch L, Zelízko M, Aschermann M, Branny M, St'ásek J, Formánek P; 'PRAGUE' Study Group Investigators. Widimský P, et al. Eur Heart J. 2003 Jan;24(1):94-104. doi: 10.1016/s0195-668x(02)00468-2. Eur Heart J. 2003. PMID: 12559941 Clinical Trial.
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial.
Widimsky P, Bilkova D, Penicka M, Novak M, Lanikova M, Porizka V, Groch L, Zelizko M, Budesinsky T, Aschermann M; PRAGUE Study Group Investigators. Widimsky P, et al. Eur Heart J. 2007 Mar;28(6):679-84. doi: 10.1093/eurheartj/ehl535. Epub 2007 Feb 13. Eur Heart J. 2007. PMID: 17298968 Clinical Trial.